# FDA drug recall: Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philad

> recall · VERIFIED · 2026-05-27

Firm: Lannett Company Inc. · Class II · Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.

- Company: Lannett Company Inc.
- Sector: pharma
- Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.